drug development
AstraZeneca licenses skin-condition drug to Leo Pharma for $115 million upfront
July 1, 2016Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Deals, Licencing, Loe Pharna, Valeant, drug development
UK drug firm AstraZeneca (LSE: AZN) said it has licenced its drug for skin diseases to Leo Pharma for an …
Roche says EMA accepts its marketing applications for Ocrevus to treat multiple sclerosis
June 28, 2016Manufacturing and Production, Research and Development, Sales and Marketing EMA, Ocrevus, Roche, US FDA, drug development, drug trial, multiple sclerosis, priority review, regulation
Cancer drugmaker Roche (SIX: ROG) said the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for its …
Novartis signs $150 million deal with Xencor to develop bispecific antibodies
June 28, 2016Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Novartis, Xencor, bispecific antibodies, deal, drug development, drug trial
Swiss drugmaker Novartis (VTX: NOVN) said it has signed a $150 million upfront collaboration and licensing agreement with Xencor to …
Takeda to return molecules/ products for Japan to Amgen
June 27, 2016Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, Japan, Takeda Pharmaceutical, drug development, drug trial
Japanese firm Takeda Pharmaceutical (TSE: 4502) said it will return the rights to develop and market multiple molecules/ products from …
Sosei‘s Heptares And Kymab to collaborate on developing new antibody therapeutics
April 18, 2016Research and Development, Sales and Marketing Heptares Therapeutics, Kymab Ltd, Sosei Group, collaboration, drug development, immuno-oncology
Japan’s Sosei Group Corp (TSE: 4565) has signed a collaboration deal with Kymab Ltd to develop and market novel antibody …
Blueprint Medicines agrees $1 billion-plus deal with Roche for cancer therapy
March 16, 2016Business Services, Research and Development, Sales and Marketing Blueprint Medicines, Deals, Immunokinases, Roche, drug development
Blueprint Medicines Corp (Nasdaq: BPMC) said it has signed an over $1 billion deal with oncology drug giant Roche (SIX: ROG) …
Onconova says Baxalta ends $565 million drug development deal for rigosertib
March 8, 2016Manufacturing and Production, Research and Development Baxalta, Onconova Therapeutics, drug development, rigosertib
Onconova Therapeutics says Baxalta has terminated its $565 million agreement to jointly develop the company’s lead drug candidate rigosertib. Baxalta …
Analysts say pharma R&D returns challenged by drag of high costs
December 16, 2015Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts
The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …
Pharma deals crucial to cutting R&D costs
December 16, 2015Research and Development GlobalData, R&D, drug development, pharma, research and development
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …
Governments and industry ‘combining to stall drug development’
November 9, 2015Research and Development, Sales and Marketing BMJ, R&D, drug development
Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …
Drugs later in development ‘winning the race to market’
November 4, 2015Research and Development R&D, drug approval, drug development, market exclusivity
Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …
Pharma ‘is getting better at drug R&D’
September 23, 2015Research and Development R&D, drug development, market access, productivity
An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
R&D firms team up to tackle antibiotic resistance
September 16, 2015Research and Development AMR, Antibiotics, Jim O'Neill, O'Neill review, antimicrobial resistance, drug development
Two companies at the centre of the UK’s R&D efforts to tackle the growing threat of resistance to antibiotics are expanding …
EMA launches project to boost early patient access to drugs
September 8, 2015Research and Development EMA, European Medicines Agency, MAPPs, adaptive pathways, drug development, market access
The EMA is launching an adaptive pathway project to bring new medicinal products to market in Europe. The ADAPT SMART …
EMA in push for more paediatric drug trials
July 24, 2015Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics
The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
